{"id":165817,"name":"BIOVERATIV INC.","slug":"bioverativ-inc","state":"MA","country":"United States of America","description":"Biopharmaceutical development","totalSpending":200000,"filings":5,"yearlySpending":[{"year":2018,"income":160000},{"year":2019,"income":40000}],"issues":["HCR","TRD"],"firms":["AVENUE SOLUTIONS"],"lobbyists":["TRACY SPICER","AMY TEJRAL"],"govEntities":["HOUSE OF REPRESENTATIVES","Intl Trade Administration (ITA)","SENATE"],"sampleDescriptions":["Issues related to healthcare discussions/offsets for budget deal and healthcare extender policies;\nH.R. 1892 / PL 115-123, Bipartisan Budget Act of 2018;\nH.R. 1625 / PL 115-141, Omnibus/Consolidated A","Trade issues/barriers to Australia and Canada","Monitor issues related to opioids policies;\n\nH.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communitie","Monitor issues related to opioids policies;\n\nH.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communitie","Monitor issues related to opioids policies;\n\nH.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communitie"],"years":[2018,2019]}